Trials / Recruiting
RecruitingNCT06482138
Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation
Dysfunction of Olfaction After SARS-CoV-2 Infection: Morphological and Histomolecular Investigation of Olfactory Cleft Biopsies and Cytobrushes
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Investigation of the mechanisms of persistent SARS-CoV-2 associated olfactory dysfunction (OD) in patients with well-documented olfactory function. The investigators plan to collect olfactory cleft biopsies and cytobrushes in COVID-19 patients and controls.
Detailed description
An explorative prospective clinical study using human body materials of living post-COVID-19 patients with and without OD, to study the mechanisms of persisting olfactory dysfunction. Patients consult ENT specialist for medical purposes and undergo standard-of-care diagnostics and management. The collected tissues from the olfactory cleft mucosa will be analyzed using single cell RNA sequencing and RNAscope combined with immunohistochemistry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biopsy and Cytobrush | Collection of olfactory cleft biopsies and cytobrushes |
Timeline
- Start date
- 2024-01-24
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-07-01
- Last updated
- 2025-03-12
Locations
7 sites across 3 countries: Belgium, Germany, Switzerland
Source: ClinicalTrials.gov record NCT06482138. Inclusion in this directory is not an endorsement.